logo
logo
logo
logo
  • Our Science
    • Therapeutics
    • Vaccination
  • Focus Areas
  • Get To Know Us
  • News & Updates
  • Get In Touch

News & Updates

May 2, 2025

CincyTech Invests in Clarametyx to Advance Breakthrough Anti-Biofilm Therapies for Chronic Respiratory Disease

Read More

January 28, 2025

Clarametyx Biosciences Announces Investment by Kineticos AMR Accelerator Fund

Read More

January 7, 2025

Clarametyx Biosciences Awarded a Multi-Phased Agreement with CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections

Read More

November 19, 2024

Clarametyx Bioscience Recognized as “Infectious Disease Innovation of the Year” In 2024 BioTech Breakthrough Awards

Read More

October 17, 2024

Clarametyx Biosciences Announces Progress on Study of Antibody Therapy CMTX-101 For Infections Associated With Cystic Fibrosis

Read More

October 9, 2024

Clarametyx to Present on Its Anti-Biofilm Technology Platform During Antimicrobial Pipeline Session At IDWeek 2024

Read More

May 28, 2024

Clarametyx Biosciences Appoints Renowned Experts to Augment Strategic and Scientific Advisory Boards

Read More

April 22, 2024

Clarametyx Biosciences Expands Team Expertise to Accelerate Pipeline Momentum

Read More

January 5, 2024

Clarametyx Biosciences Announces $33 Million Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections

Read More

Loading…

Sign-up to get updates from Clarametyx

[contact-form-7 404 "Not Found"]

Our ScienceGet To Know UsFocus Areas

News & UpdatesGet In Touch

Our ScienceFocus AreasGet To Know UsNews & UpdatesGet In Touch


Copyright © 2025 Clarametyx Biosciences. All rights reserved. Privacy Policy.